在阿尔茨海默氏病中对人类D-3-糖酸脱酶的翻译后调节
Elena Zerbini1, Daniele Riva1, Elisa Maffioli2
1Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.
Protein science : a publication of the Protein Society
|February 19, 2026
概括
在L-氨酸代谢的性别特异性影响阿尔茨海默病 (AD). 在男性中独特的PHGDH酶修饰表明AD的性别依赖的代谢脆弱性的新机制.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 代谢学 代谢学 代谢学
背景情况:
- 性别特定的代谢差异在阿尔茨海默氏症 (AD) 中越来越多地得到认可.
- 血清生物合成途径,特别是酶D-3-糖酸脱酶 (PHGDH),与这些代谢变化有关.
- 翻译后修饰 (PTMs) 是酶功能的关键调节者,可能是AD中性别特定途径失调的基础.
研究的目的:
- 在阿尔茨海默病中研究PHGDH的性别特异性PTM.
- 确定这些修改如何影响PHGDH酶活性和稳定性.
- 阐明PHGDH PTMs在AD中性别依赖的代谢脆弱性中的作用.
主要方法:
- 来自人类海马体组织的PHGDH免疫沉 (健康和AD男性/女性).
- 质谱分析用于识别和描述PTMs.
- 使用重组PHGDH变异的功能测试来评估特定修改的影响.
主要成果:
- 在所有组中都保留了PHGDH的五个酸化位.
- 在K289中观察到独特的脱乙化,仅在AD男性中观察到.
- 暴露于溶剂的部位的修改影响了溶解度,而催化裂内的酸化影响了活性;K289乙化增强了稳定性.
结论:
- PHGDH PTMs,包括在AD男性中独特的脱乙化,微调酶功能.
- 这些修改有助于阿尔茨海默病的性别依赖代谢失调.
- 针对PHGDH PTM可能为AD提供新的治疗策略,考虑性别特异性机制.
相关概念视频
Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
Phosphorylation
54.6K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
54.6K
Alzheimer's Disease: Treatment
1.0K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.0K
Neural Regulation
43.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.6K


